View in EDS

Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infection.

Saved in:
Bibliographic Details
Title: Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infection.
Authors: Mallick S; Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawaii Hilo, Hilo, HI 96720, USA; Department of Mechanical Engineering, University of Delaware, Newark, DE 19716, USA., Sharma P; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA., Yadavalli T; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA., Koganti R; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA., Singh SK; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA., Yoshimura K; Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawaii Hilo, Hilo, HI 96720, USA; Molecular Biology Institute, University of California Los Angeles, Los Angeles, CA 90095, USA., Kapoor D; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA., Sutar Y; Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University Arizona, Tucson, AZ 85721, USA., Adams JS; Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University Arizona, Tucson, AZ 85721, USA., Annaji M; Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University Arizona, Tucson, AZ 85721, USA., Shukla D; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA; Department of Bioengineering, University of Illinois at Chicago, Chicago, IL 60607, USA. Electronic address: dshukla@uic.edu., Date AA; Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawaii Hilo, Hilo, HI 96720, USA; Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University Arizona, Tucson, AZ 85721, USA; Department of Ophthalmology and Vision Science, University of Arizona College of Medicine, Tucson, AZ 85711, USA. Electronic address: abhijitdate@arizona.edu.
Source: International journal of pharmaceutics [Int J Pharm] 2026 Apr 25; Vol. 695, pp. 126672. Date of Electronic Publication: 2026 Feb 20.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41724258
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infection.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mallick+S%22">Mallick S</searchLink>; Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawaii Hilo, Hilo, HI 96720, USA; Department of Mechanical Engineering, University of Delaware, Newark, DE 19716, USA.<br /><searchLink fieldCode="AU" term="%22Sharma+P%22">Sharma P</searchLink>; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.<br /><searchLink fieldCode="AU" term="%22Yadavalli+T%22">Yadavalli T</searchLink>; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.<br /><searchLink fieldCode="AU" term="%22Koganti+R%22">Koganti R</searchLink>; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.<br /><searchLink fieldCode="AU" term="%22Singh+SK%22">Singh SK</searchLink>; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA.<br /><searchLink fieldCode="AU" term="%22Yoshimura+K%22">Yoshimura K</searchLink>; Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawaii Hilo, Hilo, HI 96720, USA; Molecular Biology Institute, University of California Los Angeles, Los Angeles, CA 90095, USA.<br /><searchLink fieldCode="AU" term="%22Kapoor+D%22">Kapoor D</searchLink>; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA.<br /><searchLink fieldCode="AU" term="%22Sutar+Y%22">Sutar Y</searchLink>; Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University Arizona, Tucson, AZ 85721, USA.<br /><searchLink fieldCode="AU" term="%22Adams+JS%22">Adams JS</searchLink>; Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University Arizona, Tucson, AZ 85721, USA.<br /><searchLink fieldCode="AU" term="%22Annaji+M%22">Annaji M</searchLink>; Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University Arizona, Tucson, AZ 85721, USA.<br /><searchLink fieldCode="AU" term="%22Shukla+D%22">Shukla D</searchLink>; Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA; Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA; Department of Bioengineering, University of Illinois at Chicago, Chicago, IL 60607, USA. Electronic address: dshukla@uic.edu.<br /><searchLink fieldCode="AU" term="%22Date+AA%22">Date AA</searchLink>; Department of Pharmaceutical Sciences, The Daniel K. Inouye College of Pharmacy, University of Hawaii Hilo, Hilo, HI 96720, USA; Department of Pharmacology and Toxicology, R. K. Coit College of Pharmacy, University Arizona, Tucson, AZ 85721, USA; Department of Ophthalmology and Vision Science, University of Arizona College of Medicine, Tucson, AZ 85711, USA. Electronic address: abhijitdate@arizona.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227804127%22">International journal of pharmaceutics</searchLink> [Int J Pharm] 2026 Apr 25; Vol. 695, pp. 126672. <i>Date of Electronic Publication: </i>2026 Feb 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2FNorth-Holland+Biomedical+Press%22">Elsevier/North-Holland Biomedical Press </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>7804127 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-3476 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203785173%22">03785173 </searchLink><i>NLM ISO Abbreviation: </i>Int J Pharm <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41724258
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ijpharm.2026.126672
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 126672
    Titles:
      – TitleFull: Topical administration of in situ gelling formulation containing myricetin-polycarboxylate nanoparticles inhibits murine genital herpes infection.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mallick S
      – PersonEntity:
          Name:
            NameFull: Sharma P
      – PersonEntity:
          Name:
            NameFull: Yadavalli T
      – PersonEntity:
          Name:
            NameFull: Koganti R
      – PersonEntity:
          Name:
            NameFull: Singh SK
      – PersonEntity:
          Name:
            NameFull: Yoshimura K
      – PersonEntity:
          Name:
            NameFull: Kapoor D
      – PersonEntity:
          Name:
            NameFull: Sutar Y
      – PersonEntity:
          Name:
            NameFull: Adams JS
      – PersonEntity:
          Name:
            NameFull: Annaji M
      – PersonEntity:
          Name:
            NameFull: Shukla D
      – PersonEntity:
          Name:
            NameFull: Date AA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 04
              Text: 2026 Apr 25
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1873-3476
          Numbering:
            – Type: volume
              Value: 695
          Titles:
            – TitleFull: International journal of pharmaceutics
              Type: main
ResultId 1